Heart surgery patients may avoid transfusions with new iron cocktail
NCT ID NCT06012760
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a combination of iron, erythropoietin, and vitamin C before major heart surgery can lower the need for blood transfusions in adults with iron-deficiency anemia. About 400 participants will receive either the combined regimen or standard care. The goal is to see if this approach is safe and effective at reducing transfusions during and after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Zhejiang University anesthesiology department
RECRUITINGHangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can less be more? testing transfusion limits in ECMO
- Could continuing a common heart drug before surgery save lives?
- A simple blood test trend may flag ICU patients at risk
- Rethinking anemia: does blood hemoglobin tell the whole story?
- Could waking up in the operating room speed heart surgery recovery?
- Can a simple frailty check predict how well seniors recover from heart surgery?